- Home
- API vs KALV Comparison
API vs KALV Comparison
Compare API & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- KALV
- Stock Information
- Founded
- API 2013
- KALV N/A
- Country
- API United States
- KALV United States
- Employees
- API N/A
- KALV N/A
- Industry
- API Computer Software: Prepackaged Software
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- API Technology
- KALV Health Care
- Exchange
- API Nasdaq
- KALV Nasdaq
- Market Cap
- API 342.9M
- KALV 796.4M
- IPO Year
- API 2020
- KALV N/A
- Fundamental
- Price
- API $3.83
- KALV $13.38
- Analyst Decision
- API Strong Buy
- KALV Strong Buy
- Analyst Count
- API 1
- KALV 8
- Target Price
- API $6.00
- KALV $26.43
- AVG Volume (30 Days)
- API 510.0K
- KALV 984.5K
- Earning Date
- API 08-18-2025
- KALV 09-11-2025
- Dividend Yield
- API N/A
- KALV N/A
- EPS Growth
- API N/A
- KALV N/A
- EPS
- API N/A
- KALV N/A
- Revenue
- API $133,554,000.00
- KALV $1,426,000.00
- Revenue This Year
- API $7.20
- KALV N/A
- Revenue Next Year
- API $11.26
- KALV $213.43
- P/E Ratio
- API N/A
- KALV N/A
- Revenue Growth
- API N/A
- KALV N/A
- 52 Week Low
- API $1.95
- KALV $7.30
- 52 Week High
- API $6.99
- KALV $17.28
- Technical
- Relative Strength Index (RSI)
- API 56.15
- KALV 43.21
- Support Level
- API $3.70
- KALV $13.26
- Resistance Level
- API $3.96
- KALV $14.25
- Average True Range (ATR)
- API 0.17
- KALV 1.03
- MACD
- API 0.04
- KALV -0.15
- Stochastic Oscillator
- API 81.43
- KALV 3.70
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.